Combined toxic effects of aflatoxin B2 and the protective role of resveratrol in Swiss albino mice
Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN,...
Saved in:
Published in | Scientific reports Vol. 11; no. 1; pp. 1 - 14 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group
10.09.2021
Nature Publishing Group UK Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
In this study, the toxic effects of aflatoxin B
2
(AFB
2
) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H
2
O
2
) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB
2
, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB
2
, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB
2
, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H
2
O
2
and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB
2
administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB
2
+ resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB
2
treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB
2
+ 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB
2
treated group. AFB
2
triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB
2
was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB
2
toxicity in all tested parameters. In this study, it was determined that AFB
2
caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects. |
---|---|
AbstractList | In this study, the toxic effects of aflatoxin B
2
(AFB
2
) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H
2
O
2
) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB
2
, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB
2
, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB
2
, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H
2
O
2
and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB
2
administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB
2
+ resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB
2
treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB
2
+ 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB
2
treated group. AFB
2
triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB
2
was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB
2
toxicity in all tested parameters. In this study, it was determined that AFB
2
caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects. Abstract In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H 2 O 2 ) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB 2 , 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB 2 , respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H 2 O 2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB 2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB 2 + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB 2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB 2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB 2 treated group. AFB 2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB 2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB 2 toxicity in all tested parameters. In this study, it was determined that AFB 2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects. Abstract In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H2O2) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB2, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H2O2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB2 + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB2 treated group. AFB2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB2 toxicity in all tested parameters. In this study, it was determined that AFB2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects. In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body weight, liver and kidney weight), biochemical (aspartate aminotransferase-AST, alanine transaminase-ALT, blood urea nitrogen-BUN, creatinine, malondialdehyde-MDA and glutathione-GSH) and cytogenetic parameters (micronucleus-MN in buccal epithelium, erythrocyte and leukocyte cells and chromosomal aberrations-CAs) were used to determine the toxic effects. Additionally, scavenging effects of resveratrol against superoxide, hydrogen peroxide (H2O2) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals were also investigated. In experimental period, mice were divided into six groups and the groups were treated with tap water, 10 mg/kg b.w resveratrol, 20 mg/kg b.w resveratrol, 20 µg/kg b.w. AFB2, 10 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, 20 mg/kg b.w resveratrol + 20 µg/kg b.w AFB2, respectively. As a result, the scavenging effects of resveratrol increased with increasing dose and the superoxide, H2O2 and DPPH radical scavenging activity of resveratrol were 74.9%, 79.1% and 49.2%, respectively. AFB2 administration caused a significant decrease in physiological parameters, and these decreases regressed in AFB2 + resveratrol treated groups. Serum ALT and AST activities, BUN and creatinine levels were higher in the AFB2 treated group compared to the control group and serious abnormalities were found in MDA and GSH levels in the kidney and liver. In the group treated with AFB2 + 20 mg/kg resveratrol, ALT, AST, BUN and creatinine levels decreased significantly and GSH levels increased compared to only-AFB2 treated group. AFB2 triggered MN formation in buccal epithelium, erythrocyte and leukocyte cells and CAs in bone marrow cells. The application of 20 mg/kg resveratrol together with AFB2 was decreased the MN and CAs frequency. Resveratrol exhibited a recovery effect in the range of 40.9–80.5% against AFB2 toxicity in all tested parameters. In this study, it was determined that AFB2 caused serious changes in selected physiological, biochemical and cytogenetic parameters while resveratrol displayed a protective role against these toxic effects. |
ArticleNumber | 18081 |
Author | Çavuşoğlu, Kültiğin Yalçın, Emine Gündüz, Alperen |
Author_xml | – sequence: 1 givenname: Alperen surname: Gündüz fullname: Gündüz, Alperen – sequence: 2 givenname: Emine surname: Yalçın fullname: Yalçın, Emine – sequence: 3 givenname: Kültiğin surname: Çavuşoğlu fullname: Çavuşoğlu, Kültiğin |
BookMark | eNpVkctuFDEQRS2UiIQkP8DKEusGvx8bJBjxiBSJBcnaqnaXkx71tAe7ZwJ_jycTIeKN7fLxKZXuG3Iy5xkJecvZe86k-1AV1951TPDOa2d9Z1-Rc8GU7oQU4uS_8xm5qnXN2tLCK-5fkzOpNHOc63PSr_KmH2cc6JJ_j5FiShiXSnOikCY4FGf6WVCYG_GAdFvy0oBxj7TkCQ9cwbrHAku70wb_fBxrpTA1a6abMeIlOU0wVbx63i_I3dcvt6vv3c2Pb9erTzddlM7ZLvE09IOXiEINomdSMQuGa_QRAZUFEBwUEyiwtykm7bXxrk8-pp4P3MoLcn30DhnWYVvGDZQ_IcMYngq53AcoyxgnDFqY9g1MitqowSqnHRPWMQPRQTKsuT4eXdtdv8Eh4rwUmF5IX77M40O4z_vglJSKmyZ49ywo-dcO6xLWeVfmNn8Q2nKmhDGuUeJIxZJrLZj-deAsHGIOx5hDizk8xRys_Aunq5wF |
CitedBy_id | crossref_primary_10_3390_ijms25052849 crossref_primary_10_3389_fnut_2022_981984 crossref_primary_10_1038_s41598_022_18791_8 crossref_primary_10_1016_j_fct_2023_114120 crossref_primary_10_1038_s41598_023_41057_w crossref_primary_10_1007_s11356_023_27436_w crossref_primary_10_1007_s11356_023_30193_5 crossref_primary_10_1038_s41598_022_15800_8 crossref_primary_10_1038_s41598_022_20115_9 crossref_primary_10_1016_j_envres_2022_114183 crossref_primary_10_1038_s41598_023_28546_8 crossref_primary_10_1038_s41598_024_58338_7 crossref_primary_10_3390_ani11123516 crossref_primary_10_1007_s11356_021_17313_9 crossref_primary_10_1038_s41598_022_08421_8 crossref_primary_10_1007_s11356_024_33625_y crossref_primary_10_1111_ijfs_17114 crossref_primary_10_1007_s00580_022_03413_6 |
Cites_doi | 10.1016/j.bbadis.2011.03.008 10.1016/j.bbrc.2003.08.105 10.1016/j.foodchem.2007.09.073 10.1016/S1383-5742(01)00059-X 10.1016/j.prp.2014.06.001 10.1073/pnas.93.4.1535 10.1006/taap.1994.1148 10.1016/0165-1218(76)90031-8 10.1016/j.tox.2009.12.007 10.1111/j.1439-0507.1998.tb00384.x 10.1016/j.phrs.2005.08.002 10.1093/alcalc/agh256 10.1016/j.mrfmmm.2004.05.019 10.5772/52866 10.1016/0165-1218(85)90067-9 10.1016/S0300-483X(01)00471-1 10.5772/51201 10.1152/physrev.00018.2001 10.1016/B978-0-323-37101-8.00035-7 10.1016/j.neuropharm.2006.05.008 10.1046/j.1365-2362.2003.01219.x 10.1289/ehp.11667 10.1038/1811199a0 10.1016/j.livsci.2008.04.006 10.1016/0002-9378(79)90708-7 10.1016/j.fct.2014.12.003 10.5505/TurkHijyen.2012.54154 10.4315/0362-028X-64.3.379 10.1186/1550-2783-2-2-38 10.1016/0027-5107(73)90118-8 10.1067/mcp.2002.125975 10.1016/j.ifset.2009.07.002 10.1093/carcin/10.6.1003 10.1007/s10534-010-9329-x 10.1042/CS20120190 10.1056/NEJMra1100831 10.1016/S1386-6346(99)00085-6 10.1007/s11356-017-0232-7 10.1590/S0102-09352011000200031 10.1136/jmg.13.2.103 10.1016/S1383-5718(02)00249-8 10.1089/jmf.2013.2885 10.1007/s11356-019-06920-2 10.1080/713654953 10.1016/j.jaubas.2011.06.002 10.1080/13813455.2019.1648516 10.1093/toxsci/55.2.383 10.5152/tud.2017.34101 10.1016/S1383-5718(98)00053-9 10.1081/JDI-65221 10.1007/s00204-007-0262-x 10.1016/j.hepres.2006.02.005 10.1016/B978-0-12-228255-3.50010-6 10.2174/0929867043363721 |
ContentType | Journal Article |
Copyright | The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PIMPY PQEST PQQKQ PQUKI PRINS Q9U 5PM DOA |
DOI | 10.1038/s41598-021-95879-7 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_5269cfa6fc564d74858027806ac8af60 10_1038_s41598_021_95879_7 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AAYXX ABDBF ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AFPKN AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU CITATION DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RIG RNT RNTTT RPM SNYQT UKHRP 7XB 8FK K9. PQEST PQUKI PRINS Q9U 5PM |
ID | FETCH-LOGICAL-c3887-f1fdbd93ee24d2b03407a615e9ceae47aa21a402e2eb7fcf595698bf9cfb1d173 |
IEDL.DBID | RPM |
ISSN | 2045-2322 |
IngestDate | Fri Oct 04 13:12:56 EDT 2024 Tue Sep 17 21:25:51 EDT 2024 Fri Sep 13 10:21:54 EDT 2024 Fri Aug 23 02:03:25 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3887-f1fdbd93ee24d2b03407a615e9ceae47aa21a402e2eb7fcf595698bf9cfb1d173 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433416/ |
PMID | 34508115 |
PQID | 2571042668 |
PQPubID | 2041939 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5269cfa6fc564d74858027806ac8af60 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8433416 proquest_journals_2571042668 crossref_primary_10_1038_s41598_021_95879_7 |
PublicationCentury | 2000 |
PublicationDate | 20210910 |
PublicationDateYYYYMMDD | 2021-09-10 |
PublicationDate_xml | – month: 9 year: 2021 text: 20210910 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Scientific reports |
PublicationYear | 2021 |
Publisher | Nature Publishing Group Nature Publishing Group UK Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group – name: Nature Publishing Group UK – name: Nature Portfolio |
References | C Kerksick (95879_CR59) 2005; 2 M Theodotou (95879_CR71) 2019; 18 TS Nawrot (95879_CR56) 2008; 116 95879_CR6 MA Murcia (95879_CR36) 2001; 64 CL Do Amaral (95879_CR43) 2008; 82 BI Agag (95879_CR4) 2004; 7 Y Li (95879_CR21) 2006; 53 FY Özatik (95879_CR26) 2017; 43 95879_CR8 RJ Verma (95879_CR50) 1998; 26 M Fenech (95879_CR31) 2003; 534 RA Dimitri (95879_CR40) 1998; 41 P Palsamy (95879_CR52) 2011; 1812 G Yentür (95879_CR1) 2011; 69 A Kasdallah-Grissa (95879_CR58) 2006; 41 AA Kheir Eldin (95879_CR60) 2008; 7 P Larsson (95879_CR5) 2000; 55 JR Savage (95879_CR35) 1976; 13 TK Macar (95879_CR75) 2020; 27 M Kitada (95879_CR19) 2013; 124 FH Anderson (95879_CR45) 2000; 18 HM Shen (95879_CR57) 1994; 127 O Kovalchuk (95879_CR67) 1998; 415 İ Gülçin (95879_CR22) 2010; 11 MN Arvind (95879_CR39) 2015; 49 B Högstedt (95879_CR63) 1985; 156 T Yoshioka (95879_CR29) 1979; 135 E Jacotot (95879_CR54) 2000; 48 CM Stein (95879_CR14) 2002; 71 SM Jeon (95879_CR42) 2014; 17 E Beutler (95879_CR30) 1963; 61 95879_CR13 EA Bailey (95879_CR66) 1996; 93 A Cuypers (95879_CR55) 2010; 23 FP Guengerich (95879_CR65) 2001; 488 WH Butler (95879_CR25) 1969; 29 LA Corcuera (95879_CR64) 2015; 76 C Ara (95879_CR72) 2005; 27 S Şener (95879_CR2) 2006; 2 E Yalcin (95879_CR28) 2010; 19 MG Theumer (95879_CR20) 2010; 268 RJ Ruch (95879_CR23) 1989; 10 G Şener (95879_CR51) 2006; 35 S Gowda (95879_CR49) 2010; 2 L Guarente (95879_CR18) 2011; 364 VS Cardoso (95879_CR41) 2011; 63 GS Bbosa (95879_CR9) 2013 S Ide (95879_CR10) 2006; 51 95879_CR69 P Maier (95879_CR62) 1976; 40 MA Te-Hsiu (95879_CR33) 1995; 11 HS Hussein (95879_CR7) 2001; 167 G Eraslan (95879_CR46) 2017; 24 A Karaca (95879_CR44) 2019; 8 T Yurdun (95879_CR12) 1995; 31 K Cavusoglu (95879_CR27) 2010; 19 AM Bakeer (95879_CR48) 2013; 25 HA Fetaih (95879_CR68) 2014; 210 H Oguz (95879_CR37) 2000; 41 XY Han (95879_CR47) 2008; 119 AD Romano (95879_CR16) 2010; 23 W Droge (95879_CR15) 2002; 82 95879_CR38 MJ O’Riordan (95879_CR3) 2008; 107 95879_CR34 JK Kundu (95879_CR74) 2004; 555 CN Ezekiel (95879_CR53) 2011; 3 MS Blois (95879_CR24) 1958; 181 95879_CR70 SS Leonard (95879_CR17) 2003; 309 GA Losa (95879_CR73) 2003; 33 L Santana (95879_CR11) 2004; 11 B Taşlı (95879_CR32) 2015; 36 M Von Ledebur (95879_CR61) 1973; 19 |
References_xml | – volume: 1812 start-page: 719 issue: 7 year: 2011 ident: 95879_CR52 publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2011.03.008 contributor: fullname: P Palsamy – volume: 309 start-page: 1017 issue: 4 year: 2003 ident: 95879_CR17 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.08.105 contributor: fullname: SS Leonard – volume: 107 start-page: 1429 issue: 4 year: 2008 ident: 95879_CR3 publication-title: Food Chem. doi: 10.1016/j.foodchem.2007.09.073 contributor: fullname: MJ O’Riordan – volume: 31 start-page: 11 year: 1995 ident: 95879_CR12 publication-title: J. Fac. Pharm. Istanbul. contributor: fullname: T Yurdun – volume: 488 start-page: 195 issue: 3 year: 2001 ident: 95879_CR65 publication-title: Mutat. Res. doi: 10.1016/S1383-5742(01)00059-X contributor: fullname: FP Guengerich – volume: 210 start-page: 1079 issue: 12 year: 2014 ident: 95879_CR68 publication-title: Pathol. Res. Pract. doi: 10.1016/j.prp.2014.06.001 contributor: fullname: HA Fetaih – volume: 93 start-page: 1535 issue: 4 year: 1996 ident: 95879_CR66 publication-title: PNAS doi: 10.1073/pnas.93.4.1535 contributor: fullname: EA Bailey – volume: 127 start-page: 145 issue: 1 year: 1994 ident: 95879_CR57 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.1994.1148 contributor: fullname: HM Shen – volume: 40 start-page: 325 issue: 4 year: 1976 ident: 95879_CR62 publication-title: Mutat. Res. Genet. Toxicol. doi: 10.1016/0165-1218(76)90031-8 contributor: fullname: P Maier – volume: 268 start-page: 104 issue: 1–2 year: 2010 ident: 95879_CR20 publication-title: Toxicology doi: 10.1016/j.tox.2009.12.007 contributor: fullname: MG Theumer – volume: 19 start-page: 2151 issue: 10 year: 2010 ident: 95879_CR28 publication-title: Fresenius Environ. Bull. contributor: fullname: E Yalcin – volume: 41 start-page: 87 issue: 1–2 year: 1998 ident: 95879_CR40 publication-title: Mycoses doi: 10.1111/j.1439-0507.1998.tb00384.x contributor: fullname: RA Dimitri – volume: 53 start-page: 6 issue: 1 year: 2006 ident: 95879_CR21 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2005.08.002 contributor: fullname: Y Li – volume: 41 start-page: 236 issue: 3 year: 2006 ident: 95879_CR58 publication-title: Alcohol Alcohol. doi: 10.1093/alcalc/agh256 contributor: fullname: A Kasdallah-Grissa – volume: 555 start-page: 65 issue: 1–2 year: 2004 ident: 95879_CR74 publication-title: Mutat. Res. Fundum. Mol. Mech. doi: 10.1016/j.mrfmmm.2004.05.019 contributor: fullname: JK Kundu – ident: 95879_CR8 doi: 10.5772/52866 – volume: 7 start-page: 119 year: 2008 ident: 95879_CR60 publication-title: Excli J. contributor: fullname: AA Kheir Eldin – volume: 156 start-page: 229 year: 1985 ident: 95879_CR63 publication-title: Mutat. Res. doi: 10.1016/0165-1218(85)90067-9 contributor: fullname: B Högstedt – volume: 167 start-page: 101 issue: 2 year: 2001 ident: 95879_CR7 publication-title: Toxicology doi: 10.1016/S0300-483X(01)00471-1 contributor: fullname: HS Hussein – volume: 29 start-page: 2206 issue: 12 year: 1969 ident: 95879_CR25 publication-title: Cancer Res. contributor: fullname: WH Butler – ident: 95879_CR38 – year: 2013 ident: 95879_CR9 publication-title: Aflatoxins Recent Adv. Future Prospects. doi: 10.5772/51201 contributor: fullname: GS Bbosa – volume: 82 start-page: 47 issue: 1 year: 2002 ident: 95879_CR15 publication-title: Physiol. Rev. doi: 10.1152/physrev.00018.2001 contributor: fullname: W Droge – ident: 95879_CR34 – ident: 95879_CR69 doi: 10.1016/B978-0-323-37101-8.00035-7 – volume: 19 start-page: 2164 issue: 10 year: 2010 ident: 95879_CR27 publication-title: Fresenius Environ. Bull. contributor: fullname: K Cavusoglu – volume: 26 start-page: 427 issue: 6 year: 1998 ident: 95879_CR50 publication-title: Med. Sci. Res. contributor: fullname: RJ Verma – volume: 7 start-page: 173 issue: 1 year: 2004 ident: 95879_CR4 publication-title: Ass. Univ. Bull. Environ. Res. contributor: fullname: BI Agag – volume: 51 start-page: 651 issue: 3 year: 2006 ident: 95879_CR10 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.05.008 contributor: fullname: S Ide – volume: 33 start-page: 818 issue: 9 year: 2003 ident: 95879_CR73 publication-title: Eur. J. Clin. Investig. doi: 10.1046/j.1365-2362.2003.01219.x contributor: fullname: GA Losa – volume: 49 start-page: 658 issue: 5 year: 2015 ident: 95879_CR39 publication-title: Indian J. Anim. Res. contributor: fullname: MN Arvind – volume: 25 start-page: 29 year: 2013 ident: 95879_CR48 publication-title: BVMJ. contributor: fullname: AM Bakeer – volume: 2 start-page: 135 issue: 46 year: 2006 ident: 95879_CR2 publication-title: Türkiye Klinikleri J. Surg. Med. Sci. contributor: fullname: S Şener – volume: 116 start-page: 1620 issue: 12 year: 2008 ident: 95879_CR56 publication-title: Environ. Health Perspect. doi: 10.1289/ehp.11667 contributor: fullname: TS Nawrot – volume: 181 start-page: 1199 year: 1958 ident: 95879_CR24 publication-title: Nature doi: 10.1038/1811199a0 contributor: fullname: MS Blois – volume: 119 start-page: 216 issue: 1–3 year: 2008 ident: 95879_CR47 publication-title: Livest. Sci. doi: 10.1016/j.livsci.2008.04.006 contributor: fullname: XY Han – volume: 61 start-page: 882 year: 1963 ident: 95879_CR30 publication-title: J. Lab. Clin. Med. contributor: fullname: E Beutler – volume: 135 start-page: 372 issue: 3 year: 1979 ident: 95879_CR29 publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/0002-9378(79)90708-7 contributor: fullname: T Yoshioka – volume: 76 start-page: 116 year: 2015 ident: 95879_CR64 publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2014.12.003 contributor: fullname: LA Corcuera – volume: 2 start-page: 170 issue: 4 year: 2010 ident: 95879_CR49 publication-title: N. Am. J. Med. Sci. contributor: fullname: S Gowda – volume: 3 start-page: 97 issue: 2 year: 2011 ident: 95879_CR53 publication-title: Arch. Appl. Sci. Res. contributor: fullname: CN Ezekiel – volume: 69 start-page: 41 issue: 1 year: 2011 ident: 95879_CR1 publication-title: Türk Hij. Den. Biyol. Derg. doi: 10.5505/TurkHijyen.2012.54154 contributor: fullname: G Yentür – volume: 64 start-page: 379 issue: 3 year: 2001 ident: 95879_CR36 publication-title: J. Food Prot. doi: 10.4315/0362-028X-64.3.379 contributor: fullname: MA Murcia – volume: 2 start-page: 38 issue: 2 year: 2005 ident: 95879_CR59 publication-title: J. Int. Soc. Sports Nutr. doi: 10.1186/1550-2783-2-2-38 contributor: fullname: C Kerksick – volume: 19 start-page: 109 issue: 1 year: 1973 ident: 95879_CR61 publication-title: Mutat. Res. Fundum. Mol. Mech. doi: 10.1016/0027-5107(73)90118-8 contributor: fullname: M Von Ledebur – volume: 48 start-page: 271 issue: 3 year: 2000 ident: 95879_CR54 publication-title: Pathol. Biol. contributor: fullname: E Jacotot – volume: 71 start-page: 411 year: 2002 ident: 95879_CR14 publication-title: Cli. Pharmacol. Ther. doi: 10.1067/mcp.2002.125975 contributor: fullname: CM Stein – volume: 18 start-page: 559 issue: 1 year: 2019 ident: 95879_CR71 publication-title: Exp. Ther. Med. contributor: fullname: M Theodotou – volume: 11 start-page: 210 issue: 1 year: 2010 ident: 95879_CR22 publication-title: Innov. Food Sci. Emerg. Technol. doi: 10.1016/j.ifset.2009.07.002 contributor: fullname: İ Gülçin – volume: 36 start-page: 63 issue: 2 year: 2015 ident: 95879_CR32 publication-title: Cumhuriyet Sci. J. contributor: fullname: B Taşlı – volume: 10 start-page: 1003 year: 1989 ident: 95879_CR23 publication-title: Carcinogenesis doi: 10.1093/carcin/10.6.1003 contributor: fullname: RJ Ruch – volume: 23 start-page: 927 issue: 5 year: 2010 ident: 95879_CR55 publication-title: Biometals doi: 10.1007/s10534-010-9329-x contributor: fullname: A Cuypers – volume: 11 start-page: 95 year: 1995 ident: 95879_CR33 publication-title: Rev. Int. Contam. Ambient. contributor: fullname: MA Te-Hsiu – volume: 124 start-page: 153 issue: 3 year: 2013 ident: 95879_CR19 publication-title: Clin. Sci. doi: 10.1042/CS20120190 contributor: fullname: M Kitada – volume: 364 start-page: 2235 issue: 23 year: 2011 ident: 95879_CR18 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1100831 contributor: fullname: L Guarente – volume: 18 start-page: 63 issue: 1 year: 2000 ident: 95879_CR45 publication-title: Hepatol. Res. doi: 10.1016/S1386-6346(99)00085-6 contributor: fullname: FH Anderson – volume: 24 start-page: 27931 issue: 36 year: 2017 ident: 95879_CR46 publication-title: Environ. Sci. Pollut. Res. doi: 10.1007/s11356-017-0232-7 contributor: fullname: G Eraslan – volume: 63 start-page: 495 issue: 2 year: 2011 ident: 95879_CR41 publication-title: Arq. Bras. Med. Vet. Zootec. doi: 10.1590/S0102-09352011000200031 contributor: fullname: VS Cardoso – volume: 13 start-page: 103 year: 1976 ident: 95879_CR35 publication-title: J. Med. Genet. doi: 10.1136/jmg.13.2.103 contributor: fullname: JR Savage – ident: 95879_CR13 – volume: 23 start-page: 29 year: 2010 ident: 95879_CR16 publication-title: J. Nephrol. contributor: fullname: AD Romano – volume: 534 start-page: 65 issue: 1 year: 2003 ident: 95879_CR31 publication-title: Mutat. Res. Genet. Toxicol. Environ. Mutagen. doi: 10.1016/S1383-5718(02)00249-8 contributor: fullname: M Fenech – volume: 17 start-page: 310 issue: 3 year: 2014 ident: 95879_CR42 publication-title: J. Med. Food. doi: 10.1089/jmf.2013.2885 contributor: fullname: SM Jeon – volume: 27 start-page: 657 issue: 1 year: 2020 ident: 95879_CR75 publication-title: Environ. Sci. Pollut. Res. doi: 10.1007/s11356-019-06920-2 contributor: fullname: TK Macar – volume: 41 start-page: 512 issue: 4 year: 2000 ident: 95879_CR37 publication-title: Br. Poult. Sci. doi: 10.1080/713654953 contributor: fullname: H Oguz – ident: 95879_CR70 doi: 10.1016/j.jaubas.2011.06.002 – volume: 8 start-page: 1 issue: 5 year: 2019 ident: 95879_CR44 publication-title: Arch. Physiol. Biochem. doi: 10.1080/13813455.2019.1648516 contributor: fullname: A Karaca – volume: 55 start-page: 383 year: 2000 ident: 95879_CR5 publication-title: Toxicol. Sci. doi: 10.1093/toxsci/55.2.383 contributor: fullname: P Larsson – volume: 43 start-page: 444 issue: 4 year: 2017 ident: 95879_CR26 publication-title: Turk. J. Urol. doi: 10.5152/tud.2017.34101 contributor: fullname: FY Özatik – volume: 415 start-page: 47 year: 1998 ident: 95879_CR67 publication-title: Mutat. Res. doi: 10.1016/S1383-5718(98)00053-9 contributor: fullname: O Kovalchuk – volume: 27 start-page: 435 issue: 4 year: 2005 ident: 95879_CR72 publication-title: Ren. Fail. doi: 10.1081/JDI-65221 contributor: fullname: C Ara – volume: 82 start-page: 363 issue: 6 year: 2008 ident: 95879_CR43 publication-title: Arch. Toxicol. doi: 10.1007/s00204-007-0262-x contributor: fullname: CL Do Amaral – volume: 35 start-page: 62 issue: 1 year: 2006 ident: 95879_CR51 publication-title: Hepatol. Res. doi: 10.1016/j.hepres.2006.02.005 contributor: fullname: G Şener – ident: 95879_CR6 doi: 10.1016/B978-0-12-228255-3.50010-6 – volume: 11 start-page: 3239 issue: 24 year: 2004 ident: 95879_CR11 publication-title: Curr. Med. Chem. doi: 10.2174/0929867043363721 contributor: fullname: L Santana |
SSID | ssj0000529419 |
Score | 2.4298747 |
Snippet | Abstract
In this study, the toxic effects of aflatoxin B
2
(AFB
2
) on Swiss albino mice and the protective effects of resveratrol were investigated.... In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological (body... In this study, the toxic effects of aflatoxin B 2 (AFB 2 ) on Swiss albino mice and the protective effects of resveratrol were investigated. Physiological... Abstract In this study, the toxic effects of aflatoxin B2 (AFB2) on Swiss albino mice and the protective effects of resveratrol were investigated.... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 1 |
SubjectTerms | Aflatoxins Alanine Alanine transaminase Albinism Aspartate aminotransferase Body weight Bone marrow Chromosome aberrations Creatinine Cytogenetics Drinking water Epithelium Erythrocytes Glutathione Hydrogen peroxide Kidneys Liver Malondialdehyde Physiology Resveratrol Superoxide Toxicity Transaminase Urea |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSxxBEG6CIOQSoknIxlX6kFsYnH5MP44qigjJJRG8Nf2oRkFmQ1xN_PdWzYxh5-TF4_QUM81X_aiPrq6Psa-pg7YqWxrpwTVapLZJSpbGR9BZeZftoN7w_Yc5v9QXV93VhtQX5YSN5YFH4A5JATvXaGrujC5Wu87RYVlrYnaxmpGti26DTI1VvaXXwk-3ZFrlDu9wp6LbZJSR0DnrGzvbiYaC_bMoc54jubHpnL1n76ZokR-Nvdxhb6DfZdujfuTjB5ZwNiOzhcLXq383mU_JGXxVeay3kRp7fix57NHiGvhUlAEXOE5ZhWSHbPuB6irjM0fjn3_RETze4ldXnJTqP7LLs9NfJ-fNJJrQZEULRhW1pOIVgNRFplYhY4sYtoDPgPjbGKWISBpBQrI11w4JknepIshJFGHVJ7bVr3r4zLgk2XQMIFNNVntRvDQgO7DKOBFjhgX79gxg-D3WxgjDmbZyYYQ7INxhgDvYBTsmjP9bUl3roQG9HSZvh5e8vWDLZw-FabLdBVx1BFFB4xbMzrw2-9n8TX9zPRTTdlrhRm6-vEbv9thbSQOMFCbaJdta_7mHfYxZ1ulgGJ5PPoHp_w priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxRBEC5iRPAi8YWrUfrgTYadfkw_TpKIYRH0ooG9Nf00gTATkzXRf2_V7Gx0Lh5npuiBqup6dFXXB_A2dqWt0uRGuGIbxWPbRCly40JRSTqbzIje8PmLXp2qT-tuvQer3V0Yaqvc2cTRUOch0Rn5ElWLU7yv7TJEOgVIm-X7yx8N4UdRnXUC07gH97nAsAI126zN3WkL1bMUd9OtmVba5TV6LrpdRh0KnTWuMTPPNA7wn0Wd857Jf5zQyQE8mqJHdrQV92PYK_0TeLDFk_z9FCLubsx0S2ab4dd5YlOzBhsqC_Ui0MueHQsWeqQ4K2wa0oAGj1GXIdFh9n1Dc5bxmSHx11sUDAsXuOrACLn-GZyefPz2YdVMIApNkmRAKq85ZidLESqL2ErM4AKGMcWlgvIwIQgeMIksokRTU-0wYXI2Vpdq5Jkb-Rz2-6EvL4AJglHHgDLWaJTj2QldRFeM1JaHkMoC3u0Y6C-3szL8WOOW1m_Z7ZHdfmS3Nws4Jh7fUdKc6_HFcPXdT9vGE_55qkHX1GmVjbKdpVJpq0Oyoep2AYc7Cflp8137v6qyADOT2uxn8y_9-dk4XNsqiY5dv_z_wq_goSDVISyJ9hD2N1c_y2uMTjbxzah4fwCIj-W9 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NaxUxEA-1IngRP_FpKzl4k9XdJJuPQylWLEWoF33QW8jHxBYeu_X1qe1_78zuvuJCLx43O2TZmUlmhkx-P8bexhbqIk2uhANbqSbWVZQiVy6AStLZZAb2htOv-mSpvpy1ZztsS3c0KfDqztKO-KSW69X76583h7jgD8Yr4_bDFQYhuihGzQatNa4y99h9oaQijz-d0v0R61s4NXB9EAh7hcmEmO7R3D3NLFYNkP6zPHTeRflPWDp-zB5N-ST_ODrAE7YD3VP2YGSYvHnGIq53rH0h801_fZH41L7B-8JDWQUa7PiR4KFDiXPgE2wDboGc-g5JDuvx34S8jM8chb_9QVPxsMJZe05c9s_Z8vjz908n1USrUCVJW0ppSo7ZSQChsoi1xJouYGIDLgFayIQgmoBlJQiIpqTSYgnlbCwuldjkxsgXbLfrO3jJuCBidUwxY4lGuSY7oUG0YKS2TQgJFuzdVoH-ckTP8MOpt7R-VLdHdftB3d4s2BHp-FaSkK-HgX79w08LyRMjeipBl9RqlY2yraXD01qHZEPR9YLtbS3kt97kcV9qqFjUdsHMzGqzj83fdBfnA9y2VRJDvX71X__ymj0U5ElENlHvsd3N-hfsY_qyiW8Gn_wL4lXrBw priority: 102 providerName: Scholars Portal |
Title | Combined toxic effects of aflatoxin B2 and the protective role of resveratrol in Swiss albino mice |
URI | https://www.proquest.com/docview/2571042668/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC8433416 https://doaj.org/article/5269cfa6fc564d74858027806ac8af60 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBY5KPSlND3otumih74VZ63DOh67ISEENoS0gX0TOpuFjR2S7fXvO5K9Zf3aF4Pt8cHMaDQfGs2H0CfXxDoxGSqqo6o4cXXlGA2VtpF7ppWXhb1hcSUubvnlslnuoWa7F6YU7Xu3OmnX9yft6q7UVj7c-9m2Tmx2vThVnEHwFbN9tC8Z24HofUNvqjnRwwaZmqnZE0xSeSNZLkZolNRVZt5jHFITktlwd-aj0rZ_lGuOKyV3pp7zl-jFkDPiL_2_HaG92L5Cz3oWyT-vkYMxDfg2Brzpfq88Hko0cJewTWubL7Z4TrFtQeIu4qE1A4Q5nGsLsxxg7p-5uzKcYxD--gvMge0a3trhzFf_Bt2en307vagG6oTKsxw2EknBBc1ipDxQVzPAbRaSl6h9BCtIaymxAB0jjU4mnxqASVq5pH1yJBDJ3qKDtmvjO4RpJk-HNNIlJ7kmQVMRaRMlE4pY6-MEfd4q0Dz0HTJMWdlmyvSaN6B5UzRv5ATNs47_Sebu1uVC9_jdDDY2mfXcJyuSbwQPkqtG5QXSWlivbBL1BB1vLWSGIfdkIPaQDAiFmiA5stroY-M74GGlpfbgUe__-8kP6DnNDpbJJepjdLB5_BE_QrqycVNw0qWcosP52dX1zbSAfjguuJoWx_0LvnvvQw |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,33779,43345,43840,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxQxDI6gCMGl4imWFsiBGxp18pg8TogiqgXaXmilvUV50krVTOkutPx77NlsYS4cJ2Mlku04duz4I-Rt6HJbhE4Nt9k0koW2CYKnxvoso7Am6hG94ehYzU_ll0W3qBduy1pWubGJo6FOQ8Q78j1QLYb-vjLvL380iBqF2dUKoXGX3JNCSCzp0wt9e8eCWSzJbH0r0wqzt4TzCt-UYV1CZ7Rt9OQ8Gtv2T3zNaaXkP0fPwSOyXX1G-mEt5MfkTu6fkPtrFMnfT0mAPQ3xbU50NdycR1pLNOhQqC8XHgd7us-p74HiLNPamgHMHMXaQqSDmPsXdleGbwrE365BHNRfwKwDRbz6Z-T04NPJx3lToROaKNBsFFZSSFbkzGXioRUQt3lwXrKNGaSgvefMQ-iYeQ66xNJBmGRNKDaWwBLT4jnZ6oc-vyCUI3g6uJGhBC0tS5arzLushTLM-5hn5N2Gge5y3SHDjZltYdya3Q7Y7UZ2Oz0j-8jjW0rsbj0ODFffXd0sDlHPY_GqxE7JpKXpDCZIW-Wj8UW1M7K7kZCrW27p_irIjOiJ1CaLTf_052djS22D6sPUy_9P_IY8mJ8cHbrDz8dfd8hDjmqEaBLtLtlaXf3Mr8A_WYXXoxL-AXBE5PA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFYhLVV5ioYAP3FC0ie34cUIsdFVeqwqo1JvlZ1upSkp3gfbfM5P1FnLhGGfkSDPjeWTG8xHyyrepzlzFipmkK9H4uvKcxcq4JAI3OqgBveHLQh4ciY_H7XHpf1qWtsqNTRwMdewD_iOfgmo1GO9LPc2lLeLw_fzNxY8KEaSw0lrgNG6TbSVkCxq-PdtfHH69-eOCNS3RmHJzpuZ6ugTvhTfMsEuh1cpUauSdhiH-o8hz3Df5jyOa75KdEkHSt2uR3ye3UveA3FljSl4_JB5OOGS7KdJVf3UWaGnYoH2mLp87XOzojFHXAcVpomVQAxg9ip2GSAcZ-C-ctQzPFIi__QbhUHcOu_YU0esfkaP5_vd3B1UBUqgCRyOSmxx9NDwlJiLzNYcszkEok0xIIBPlHGscJJKJJa9yyC0kTUb7bEL2TWwUf0y2ur5LTwhlCKUOQaXPXgnTRMNkYm1SXOrGuZAm5PWGgfZiPS_DDnVuru2a3RbYbQd2WzUhM-TxDSXOuh4W-ssTW46ORQz0kJ3MoZUiKqFbjeXSWrqgXZb1hOxtJGTLAVzav-oyIWoktdHHxm-6s9NhwLYWHJy7fPr_jV-Su6CB9vOHxadn5B5DLUJoiXqPbK0uf6bnEKys_IuihX8AAizqkw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+toxic+effects+of+aflatoxin+B2+and+the+protective+role+of+resveratrol+in+Swiss+albino+mice&rft.jtitle=Scientific+reports&rft.au=G%C3%BCnd%C3%BCz%2C+Alperen&rft.au=Yal%C3%A7%C4%B1n%2C+Emine&rft.au=%C3%87avu%C5%9Fo%C4%9Flu%2C+K%C3%BClti%C4%9Fin&rft.date=2021-09-10&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-95879-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_021_95879_7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |